Crescent Biopharma CBIO Growth Metrics (2013-2026)

NASDAQ CBIO
$14.76 +0.23 (+1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Crescent Biopharma Quarterly Growth Metrics

Periods 53 quarters
Latest Jun 2026

Crescent Biopharma reported asset growth of 16.09% for the quarter ended Jun 2026. These growth metrics cover 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-28.24%-33.95%-40.98%-47.70%-48.16%-45.08%-15.40%-4.95%-4.93%-12.53%-50.37%-60.50%-70.49%-21.40%-82.48%544.72%780.80%574.66%3,223.16%16.09%
Assets Growth (3y)
-21.74%-23.99%-26.41%-30.33%-32.31%-32.43%-24.80%-26.91%-29.28%-31.80%-37.19%-41.88%-47.41%-27.73%-58.10%34.26%35.19%66.77%42.43%43.52%
Assets Growth (5y)
17.59%17.35%16.99%-11.77%-13.54%-16.62%-22.56%-23.48%-25.07%-26.75%-30.06%-33.82%-38.64%-26.67%-48.29%-0.12%-1.67%10.96%7.61%8.00%
Assets (QoQ)
-13.21%-12.60%-13.65%-20.16%-13.96%-7.42%33.03%-10.30%-13.94%-14.82%-24.52%-28.61%-35.71%126.89%-83.18%2,527.31%-12.17%73.79%-17.13%-8.22%
Capital Expenditures Growth (1y)Capex Growth (1y)
-72.59%-93.59%1,224.22%707.25%-42.71%-99.96%-94.58%-74.43%216.79%80,000.00%238.60%-75.94%5,427.04%-90.71%
Capital Expenditures Growth (3y)Capex Growth (3y)
-45.35%-64.99%0.82%-18.03%-48.58%-95.67%-35.36%18.16%-20.77%-72.42%34.46%-20.82%50.36%517.98%5,679.00%305.97%7.28%
Capital Expenditures Growth (5y)Capex Growth (5y)
-54.63%-64.57%-8.44%-24.16%-40.28%-87.61%-33.28%-16.17%-21.60%-57.39%-28.40%-49.19%85.45%105.96%38.28%116.93%20.57%
Capital Expenditures (QoQ)Capex (QoQ)
-15.05%-43.54%1,555.95%1.64%-93.97%-99.96%219,600.00%379.29%-25.30%-89.82%828.71%-65.95%318.57%-67.06%-23.83%-91.16%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-28.66%-34.14%-42.24%-49.31%-49.35%-46.96%-15.05%-3.66%-4.29%-12.70%-51.85%-61.40%-70.85%-16.81%-28.34%581.45%825.69%513.22%743.55%12.42%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-22.60%-24.52%-26.86%-31.10%-32.90%-32.86%-25.12%-27.11%-29.81%-32.69%-38.18%-42.67%-47.92%-27.24%-33.57%36.33%37.19%64.53%42.78%43.53%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
17.62%17.65%17.21%-12.75%-14.48%-17.32%-23.16%-24.04%-25.81%-27.59%-30.68%-34.38%-39.03%-26.14%-32.05%0.37%-1.38%9.24%7.39%7.62%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-14.24%-11.45%-15.22%-21.27%-14.31%-7.27%35.79%-10.72%-14.87%-15.41%-25.11%-28.43%-35.71%141.43%-35.49%580.57%-12.67%59.93%-11.25%-9.30%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
72.59%93.59%-1,224.22%-707.25%42.71%99.96%94.58%74.43%-216.79%-80,000.00%-238.60%75.94%-5,427.04%1,355.00%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
45.35%64.99%-0.82%18.03%48.58%95.67%35.36%-18.16%20.77%72.42%-34.46%20.82%-50.36%-517.98%-41,538.82%-1,447.83%452.72%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
54.63%64.57%8.44%24.16%40.28%87.61%33.28%16.17%21.60%57.39%28.40%49.19%-85.45%-105.96%-352.21%-384.23%222.04%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
15.05%43.54%-1,555.95%-1.64%93.97%99.96%-219,600.00%-379.29%25.30%89.82%-828.71%65.95%-318.57%-12,219.62%88.71%121.57%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-47.31%-32.22%3.02%-19.24%49.15%38.22%15.27%57.03%-0.77%3.75%9.46%-27.51%7.89%17.68%-3.26%-84.43%-119.40%-326.42%17.64%-18.66%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-18.89%-8.67%1.53%-12.51%13.79%14.80%-49.12%21.74%8.95%7.71%9.39%13.23%22.14%21.19%7.47%-0.35%-26.75%-50.06%8.34%-40.79%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-17.80%-16.55%-8.62%-21.59%-6.70%1.12%-2.60%11.79%2.95%5.27%6.04%4.84%9.87%13.29%-25.39%-2.42%-8.81%-22.51%8.75%-7.41%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-24.50%24.43%-6.96%-18.49%46.91%8.19%-46.71%39.91%-24.49%12.30%-38.00%15.37%10.07%21.62%-73.09%-51.16%-6.98%-52.35%66.57%-117.78%
EBITDA Margin Growth (1y)
-1.86M-8.90M1,007.87M
EBITDA Margin Growth (3y)
EBITDA Margin Growth (5y)
2.24M-0.10M
EBITDA Margin (QoQ)
1,007.65M-7.86M
EBIT Growth (1y)
-26.30%-11.93%-2.66%7.30%49.43%39.04%25.37%33.12%-11.93%9.71%-1.59%-15.99%-14.47%-79.24%-27.97%-103.04%-130.42%-432.21%-73.85%-25.36%
EBIT Growth (3y)
-11.46%-5.22%1.05%7.40%14.66%11.52%-10.50%14.13%10.58%14.91%8.01%10.41%13.47%0.45%1.00%-16.35%-43.46%-104.98%-31.23%-43.46%
EBIT Growth (5y)
-17.06%-15.83%-12.96%-10.13%-1.39%-2.18%2.07%5.97%4.75%8.51%5.99%9.24%4.45%-2.31%-11.90%-8.32%-13.53%-42.50%-11.61%-12.85%
EBIT Margin Growth (1y)
-1.87M-8.93M1,012.62M
EBIT Margin Growth (3y)
EBIT Margin Growth (5y)
2.26M-0.10M
EBIT Margin (QoQ)
1,012.40M-7.88M
EBIT (QoQ)
-20.36%-0.51%15.87%8.92%34.34%-21.16%-3.00%18.38%-9.89%2.27%-15.89%6.81%-8.46%-53.03%17.26%-47.85%-23.09%-253.46%72.97%-6.61%
EBT Growth (1y)
-26.30%-11.93%-2.66%7.30%49.43%39.04%25.37%33.12%-11.93%9.71%-1.59%-15.99%-14.47%-86.29%-36.28%-110.38%-119.04%-405.94%-53.70%-13.98%
EBT Growth (3y)
-11.46%-5.22%1.05%7.40%14.66%11.52%-10.50%14.13%10.58%14.91%8.01%10.41%13.47%-0.84%-1.10%-17.73%-41.06%-104.16%-28.63%-40.63%
EBT Growth (5y)
-17.06%-15.83%-12.96%-10.13%-1.39%-2.18%2.07%5.97%4.75%8.51%5.99%9.24%4.45%-3.10%-13.32%-9.09%-12.38%-42.16%-10.27%-11.51%
EBT Margin Growth (1y)
-1.87M-8.93M1,012.62M
EBT Margin Growth (3y)
EBT Margin Growth (5y)
2.26M-0.09M
EBT Margin (QoQ)
1,012.40M-7.88M
EBT (QoQ)
-20.36%-0.51%15.87%8.92%34.34%-21.16%-3.00%18.38%-9.89%2.27%-15.89%6.81%-8.46%-59.05%15.22%-43.85%-12.93%-267.36%74.24%-6.67%
EPS (Basic) Growth (1y)
-16.38%0.53%0.55%9.39%51.63%42.40%38.70%49.25%12.05%26.50%2.96%-21.84%-6.53%-93.34%-40.94%-3,508.64%-876.45%-707.44%-226.25%85.60%
EPS (Basic) Growth (3y)
-7.74%0.02%4.97%11.61%19.01%16.95%0.80%26.33%20.89%25.05%16.05%17.56%23.18%6.46%5.70%-181.54%-109.15%-125.54%-64.63%-84.99%
EPS (Basic) Growth (5y)
0.27%2.88%3.68%3.27%7.72%9.14%12.12%13.38%11.85%15.81%12.58%15.65%13.02%4.03%-5.95%-77.41%-38.80%-45.73%-22.16%-23.83%
EPS (Basic) (QoQ)
-20.31%-0.73%17.30%9.59%35.77%-19.94%11.98%25.15%-11.30%-0.22%-16.22%6.01%2.69%-81.88%15.28%-2,306.41%73.67%-50.40%65.77%-6.21%
EPS (Diluted) Growth (1y)
-5.95%0.53%0.55%9.39%51.63%42.40%38.70%49.25%12.05%26.50%2.96%-21.84%-6.53%-93.34%-11,682.14%-3,508.64%-876.45%-707.44%96.10%85.60%
EPS (Diluted) Growth (3y)
16.86%21.60%26.72%31.85%37.61%16.95%1.05%26.64%23.33%25.05%16.05%17.56%23.18%6.46%-312.31%-181.54%-109.15%-125.54%-64.63%-84.99%
EPS (Diluted) Growth (5y)
3.27%4.25%6.92%9.25%16.55%16.05%21.66%25.76%24.55%27.24%25.20%27.83%25.63%4.03%-156.39%-76.97%-36.21%-45.73%-22.16%-23.83%
EPS (Diluted) (QoQ)
-20.31%-0.73%17.30%9.59%35.77%-19.94%11.98%25.15%-11.30%-0.22%-16.22%6.01%2.69%-81.88%-6,982.34%71.21%73.67%-50.40%65.77%-6.21%
FCF Margin Growth (1y)
-1.84M-6.67M956.74M
FCF Margin Growth (3y)
FCF Margin Growth (5y)
2.20M0.05M
FCF Margin (QoQ)
956.95M-5.31M
Free Cash Flow Growth (1y)FCF Growth (1y)
-47.14%-31.72%2.76%-19.50%49.15%38.23%15.50%57.07%-0.83%3.74%9.41%-27.35%7.98%17.68%-3.18%-85.95%-126.72%-329.49%16.28%-17.74%
Free Cash Flow Growth (3y)FCF Growth (3y)
-18.80%-8.47%1.53%-12.36%13.82%14.83%-49.02%21.71%8.96%7.82%9.37%13.23%22.15%21.19%7.56%-0.55%-28.13%-50.42%7.85%-40.75%
Free Cash Flow Growth (5y)FCF Growth (5y)
-17.10%-14.91%-8.53%-21.01%-6.60%1.20%-2.57%11.79%2.98%5.37%6.08%4.96%9.90%13.31%-25.34%-2.59%-9.50%-22.59%8.45%-7.42%
Free Cash Flow (QoQ)FCF (QoQ)
-24.49%24.43%-7.26%-18.44%47.03%8.21%-46.74%39.83%-24.42%12.37%-38.08%15.41%10.10%21.62%-73.09%-52.45%-9.62%-48.49%66.26%-114.40%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
36.60%-53.22%
Net Cash Flow Growth (1y)NCF Growth (1y)
-142.75%-99.98%-201.00%-19.50%49.09%32.20%224.70%57.19%-0.11%3.75%-161.36%-27.71%7.32%556.56%-17.37%1,565.05%-142.40%129.92%-94.77%-113.48%
Net Cash Flow Growth (3y)NCF Growth (3y)
-20.79%-5.59%1.46%-12.61%13.42%14.56%91.94%-11.84%-7.36%-9.28%-32.06%13.23%22.12%70.76%3.52%115.51%-31.02%129.60%-50.41%-36.13%
Net Cash Flow Growth (5y)NCF Growth (5y)
-16.76%-17.36%-20.31%-17.00%-6.55%-22.12%-32.10%12.00%2.12%5.13%6.04%4.83%9.64%36.51%-29.57%94.97%-22.69%73.45%-39.40%-5.23%
Net Cash Flow (QoQ)NCF (QoQ)
-24.33%31.07%-17.73%-18.44%47.03%8.21%316.54%-140.66%-23.89%11.76%-38.04%15.37%10.09%534.69%-135.49%1,156.35%-114.88%512.31%-130.06%26.88%
Net Income Growth (1y)
-26.31%-11.95%-2.66%7.86%50.82%41.20%29.30%37.75%-7.96%11.38%-3.64%-22.24%-6.76%20.69%78.17%-115.84%-150.47%-1,155.51%-893.41%-13.98%
Net Income Growth (3y)
-11.45%-5.21%1.07%7.60%13.68%11.39%-10.57%16.29%12.47%16.44%9.06%11.16%17.24%25.51%45.72%-17.98%-42.39%-106.64%-30.99%-44.34%
Net Income Growth (5y)
-17.06%-15.82%-12.95%-9.98%-0.82%-1.44%3.14%7.43%5.97%9.51%6.63%9.70%5.81%13.33%21.09%-9.13%-12.39%-42.17%-10.28%-11.52%
Net Income (QoQ)
-20.37%-0.52%15.89%9.46%35.75%-20.18%-1.12%20.28%-11.43%1.35%-18.26%5.97%2.69%26.71%67.45%-829.71%-12.93%-267.36%74.24%-6.67%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-26.31%-11.95%-2.66%7.86%50.82%41.20%29.30%37.75%-7.96%11.38%-3.64%-22.24%-6.76%-96.80%-41.09%-115.84%-150.47%-30.41%-53.70%-13.98%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-14.40%-7.80%-1.33%5.72%13.68%11.39%-10.57%16.29%12.47%16.44%9.06%11.16%17.24%-0.84%-1.11%-17.98%-42.39%-31.51%-30.99%-44.34%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-17.15%-15.91%-13.06%-10.26%-1.40%-2.05%2.09%6.04%4.48%8.18%5.28%8.60%5.81%-3.94%-14.60%-9.13%-12.39%-8.41%-10.28%-11.52%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-20.37%-0.52%15.89%9.46%35.75%-20.18%-1.12%20.28%-11.43%1.35%-18.26%5.97%2.69%-81.86%15.22%-43.85%-12.93%5.31%0.07%-6.67%
Net Margin Growth (1y)
-1.87M-8.93M1,012.26M
Net Margin Growth (3y)
Net Margin Growth (5y)
2.24M-0.09M
Net Margin (QoQ)
1,012.03M-7.88M
Operating Income Growth (1y)Op. Inc Growth (1y)
-26.30%-11.93%-2.66%7.30%49.43%39.04%25.37%33.12%-11.93%9.71%-1.59%-15.99%-14.47%-79.24%-27.97%-103.04%-130.42%-432.21%-73.85%-25.36%
Operating Income Growth (3y)Op. Inc Growth (3y)
-11.46%-5.22%1.05%7.40%14.66%11.52%-10.50%14.13%10.58%14.91%8.01%10.41%13.47%0.45%1.00%-16.35%-43.46%-104.98%-31.23%-43.46%
Operating Income Growth (5y)Op. Inc Growth (5y)
-17.06%-15.83%-12.96%-10.13%-1.39%-2.18%2.07%5.97%4.75%8.51%5.99%9.24%4.45%-2.31%-11.90%-8.32%-13.53%-42.50%-11.61%-12.85%
Operating Income (QoQ)Op. Inc (QoQ)
-20.36%-0.51%15.87%8.92%34.34%-21.16%-3.00%18.38%-9.89%2.27%-15.89%6.81%-8.46%-53.03%17.26%-47.85%-23.09%-253.46%72.97%-6.61%
Operating Margin Growth (1y)
-1.87M-8.93M1,012.62M
Operating Margin Growth (3y)
Operating Margin Growth (5y)
2.26M-0.10M
Operating Margin (QoQ)
1,012.40M-7.88M
Profit After Tax Growth (1y)PAT Growth (1y)
-26.30%-11.93%-2.66%7.30%49.43%39.04%25.37%33.12%-11.93%9.71%-1.59%-15.99%-14.47%-86.29%-36.28%-110.38%-119.04%-405.94%-53.70%-13.98%
Profit After Tax Growth (3y)PAT Growth (3y)
-11.46%-5.22%1.05%7.40%14.66%11.52%-10.50%14.13%10.58%14.91%8.01%10.41%13.47%-0.84%-1.10%-17.73%-41.06%-104.16%-28.63%-40.63%
Profit After Tax Growth (5y)PAT Growth (5y)
-17.06%-15.83%-12.96%-10.13%-1.39%-2.18%2.07%5.97%4.75%8.51%5.99%9.24%4.45%-3.10%-13.32%-9.09%-12.38%-42.16%-10.27%-11.51%
Profit After Tax (QoQ)PAT (QoQ)
-20.36%-0.51%15.87%8.92%34.34%-21.16%-3.00%18.38%-9.89%2.27%-15.89%6.81%-8.46%-59.05%15.22%-43.85%-12.93%-267.36%74.24%-6.67%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-35.30%-40.57%-36.75%-32.20%-32.69%-34.28%-42.65%-49.59%-53.84%353.89%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-23.83%-27.23%-28.61%-28.99%-31.04%-33.46%-35.92%-38.11%-41.42%-16.62%39.49%51.69%66.64%73.45%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-8.75%-18.98%-20.09%-22.09%-23.81%-26.20%-28.24%-30.16%-32.77%-22.89%3.40%6.39%10.91%12.27%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-12.84%-13.83%-5.09%-4.88%-13.47%-15.87%-17.18%-16.38%-20.78%305.18%8.18%9.81%-5.71%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M236.000.00M0.00M0.00M-0.00M-0.01M-0.01M-0.01M-0.00M0.01M0.02M0.01M0.01M-0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M0.01M0.00M-263.00-0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
952.00790.00863.00-0.00M-0.01M-0.01M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M-0.00M-533.00-0.00M-0.00M-0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-883.00-971.00-988.00-0.00M-347.00239.000.00M0.00M-900.00-872.00-0.00M-0.00M-0.01M0.01M592.000.01M0.00M-0.00M65.00-0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M350.000.00M0.00M0.00M-0.00M-0.01M-0.02M-0.02M-0.02M0.01M0.02M0.02M0.02M30.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.02M-0.02M-0.02M-41.000.00M571.00208.00-0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M670.00-0.01M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.02M-0.03M-0.03M-0.01M-0.00M-0.01M-0.00M-0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-989.00-0.00M-0.00M-0.00M-515.00-258.000.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.00M0.00M0.02M0.00M-0.00M0.00M-0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-0.00M-0.00M-0.00M-0.01M-0.00M-0.00M462.000.00M0.00M0.00M-0.00M-0.01M-0.03M0.01M0.04M-0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.04M0.00M0.01M0.00M-209.00-0.00M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.04M-0.00M-838.00-0.00M-0.00M-0.00M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-0.00M-0.00M-0.00M-0.00M-246.00118.000.00M0.00M-0.00M-0.00M-0.00M-0.00M-0.03M0.00M-0.00M430.00-0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-1.87M-8.93M1,012.62M-1.02M4.77M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
3.23M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
2.26M4.24M14.68M-0.10M1,012.78M
Return on Sales [ROS] (QoQ)ROS (QoQ)
1,012.40M-7.88M-1.24M-2.09M-1.38M
Revenue Growth (1y)
-91.34%-89.18%52,716.90%
Revenue Growth (3y)
Revenue Growth (5y)
36.15%-0.31%
Revenue (QoQ)
60,857.75%-79.64%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
-5.89%-18.89%-33.05%-38.31%-42.55%-31.88%-19.48%-10.96%-2.86%1.02%36.99%40.70%28.19%24.84%3.10%342.30%74.50%318.43%234.66%-25.75%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
10.75%4.71%-7.88%-14.08%-16.80%-19.54%-21.84%-21.32%-19.32%-17.67%-9.61%-8.23%-10.56%-4.94%4.38%76.95%29.52%74.10%67.82%66.56%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
16.56%12.70%5.10%-0.56%-1.03%-1.39%-4.85%-5.69%-5.39%-4.60%-2.92%-4.49%-6.43%-8.06%-7.57%24.83%3.28%23.86%20.57%20.48%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
1.84%-17.02%-18.14%-10.82%-5.17%-1.62%-3.23%-1.39%3.47%2.31%31.23%1.28%-5.73%-0.36%8.38%334.50%-62.81%138.92%-13.32%-3.60%

Crescent Biopharma Growth Metrics API

Pull Crescent Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CBIO&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY